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SUMMARY
Aim of our study was complex detection of appearance and distribution of specifi c sig-
nalling proteins and apoptosis in facial tissue of children with complete bilateral cleft lip and 
palate (CBCLP).
Materials and methods. Nineteen CBCLP patients and 11 unaffected subjects were involved 
in this study. All the tissue samples were proceeded for detection of matrix metalloproteinase-2 
(MMP-2), tissue inhibitor of matrix metalloproteinase-2 (TIMP-2), and apoptosis. The intensity 
of immunostaining was graded semi-quantitatively. Results of the terminal deoxynucleotidyl 
transferase mediated dUTP nick-end labeling (TUNEL) method were obtained by counting 
apoptosis positive cells in fi ve unintentionally chosen fi elds of vision. Groups were compared 
using the Mann-Whitney test.
Results. TUNEL-positive oral epithelial cells were signifi cantly increased in the control 
group when compared with the CBCLP group. Connective tissue cells have a statistically 
signifi cant lower expression of TIMP-2 in the control group compared to the CBCLP group.
Conclusions. TIMP-2 positive connective tissue cells increasingly found in oral mucosa 
lamina propria proves the decrease of local apoptosis in CLP patients. Prominent expression of 
MMP-2 in cleft affected soft tissue indicates a possible increase of tissue remodelling.
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Cleft lip and palate (CLP) is among the most 
common genetically heterogeneous and multifacto-
rial congenital malformation of the head and neck in 
humans. These defects account for approximately 65 
% of all head and neck anomalies. The prevalence of 
CLP ranges from 3.4 to 22.9 per 10 000 births (1, 2).
Matrix metalloproteinases (MMPs) are a family 
of zinc- and calcium-dependent proteinases that are 
responsible for tissue remodelling, cell migration, 
adhesion and proliferation. MMPs participate in 
biological processes, such as embryonic develop-
ment, growth, morphogenesis and wound healing. 
MMPs can also process and regulate activity of 
non – extracellular matrix proteins, such as growth 
factors, cytokines, cell receptors and other MMPs 
(3-5). Analysis showed that MMP-2, MMP-3 play an 
important role in palate development. Brown et al. 
(2002) found an immunohistochemical increases in 
MMP-2 during mice palatogenesis (6). MMP-2 plays 
a specifi c role in epithelial migration (7).
Tissue inhibitors of matrix metalloproteinases 
(TIMPs) are able to inhibit MMPs, cell growth activity 
and angiogenesis alike. TIMPs can also promote cell 
growth activity and modulate cell apoptosis. TIMP-2 
is involved in the activation of pro-MMP-2 and stimu-
lates the proliferation of dental pulp, fi broblast – like 
cells, gingival fi broblasts, as well as epithelial cells. 
In addition, TIMP-1 and TIMP-2 also have anti – ap-
optotic effects (8, 9). If MMP and TIMP balance is 
disrupted CLP can occur (10-13). Variation in MMP-
2, MMP-3, TIMP-2 signalling that pathway genes are 
likely to be involved in the development of CLP (14).
Apoptosis is a morphological process that plays 
a central role in embryonic development, morphogen-
esis, tissue remodelling and normal tissue turnover 
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Fig. 1. Numerous MMP-2 immunoreactive oral epithelial 
cells, especially in the basal cell layer from cleft lip region 
of 3 months old child. MMP-2 IMH, ×250
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(15). Oral epithelial cells apoptosis play a critical 
role in regulating oral mucosa development and ho-
meostasis. Specifi c control of apoptosis is essential 
for correct formation of the lip and palate. Failure of 
apoptosis to occur in the epithelial edge can result 
in the development CLP (16). Genetic variations 
in genes of the mitochondrial – mediated apoptotic 
signalling pathway that block cell death may play an 
etiological role in CLP (17).
Many studies support that MMPs, TIMPs and 
apoptosis participate in the etiology of CLP. Moreo-
ver, still a little is known about local expression of 
MMP-2, TIMP-2 and apoptosis in facial tissue of 
children with CBCLP. 
Thus, we aimed to determine the apoptotic cells 
by the TUNEL method and MMP-2, TIMP-2 expres-
sion in facial tissue of children with CBCLP.
MATERIALS AND METHODS
Patients
Nineteen CBCLP patients and 11 unaffected 
subjects were involved in this study. Samples of soft 
tissue were collected during the surgical correction of 
cleft at the age of 3 months to 8 years and 5 months 
or in the case of tooth extraction in controls at the age 
of 6 years and 9 months to 14 years and 5 months. All 
information about the patients is summarized 
in Table 1. This study has been independently 
reviewed and approved by the local Ethi-
cal Committee of Riga Stradins University 
(2007), and written informed consent was 
obtained from all parents after the nature of 
the study had been fully explained. Among 
affected patients there were 14 males and 5 
females, whereas among controls there were 
5 males and 6 females.
Methods
1) For conventional light microscopy and 
immunohistochemistry tissues were fi xed for 
a day in mixture of 2% formaldehyde and 
0.2% picric acid in 0.1 M phosphate buffer 
(pH 7.2). Following this, they were rinsed in 
thyroid buffer, containing 10% sacharose for 
12 hours, and then samples were embedded 
into paraffin. Five micrometer thick sec-
tions were cut from each block, mounted on 
glass slides then de-paraffi nized, rehydrated 
through graded alcohol solutions and colored 
with hematoxylin-eosin.
2) Immunohistochemistry (IMH) (18).
Five-micrometer thick sections were cut 
from the same blocks and placed on polyli-
sine coated slides for immunohistochemical analysis. 
MMP-2 (cat No AF902, LOT DUBO 34081, obtained 
from goat, 1:100 dilution, R&D Systems, Germany) 
and TIMP-2 (cat No 3A4, sc – 21735, obtained from 
mouse, 1:200 dilution, Santa Cruz Biotechnology, 
INC) were used by biotin-streptavidin IMH.
3) Paraffi n sections were also placed on polyli-
sine coated slides to perform TUNEL method. For 
TUNEL method we used In situ Cell Death Detection 
Kit (Pod cat No 11684817910, Roche Diagnostics, 
Germany) in accordance to Negoescu et al. (19). The 
Table. Information about the patients
Patient Gender Age Plastic surgery 
procedure
Material
No. 1 M 3 months Lip plastic Cleft lip region
No. 2 F 3 months Lip plastic Cleft lip region
No. 3 M 4 months Lip plastic Cleft lip region
No. 4 M 4 months Lip plastic Cleft lip region 
No. 5 M 4 months Lip plastic Cleft lip region 
No. 6 M 4 months Lip plastic Cleft lip region 
No. 7 M 4 months Lip plastic Cleft lip region
No. 8 F 5 months Lip plastic Cleft lip region
No. 9 M 6 months Lip plastic Cleft lip region
No. 10 M 6 months Lip plastic Cleft lip region
No. 11 M 7 months Lip plastic Cleft lip region
No. 12 M 7 months Lip plastic Cleft lip region
No. 13 F 7 months Lip plastic Cleft lip region
No. 14 M 10 months Lip plastic Cleft lip region
No. 15 M 10 months Lip plastic Cleft lip region
No. 16 F 11 months Lip plastic Cleft lip region
No. 17 F 11 months Lip plastic Cleft lip region 
No. 18 M 8 years 5 
months 
Lip plastic Cleft lip region
No. 19 M 8 years 5 
months
Lip plastic Cleft lip region
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sections were pre – treated with Proteinase K (10 
μg/ml), incubated with the TUNEL reaction mixture 
with TdT Enzyme and then Anti-FITC HRP conju-
gated at 37˚C. DAB was also used as the chromogen. 
TUNEL-positive if the nucleus showed a dark brown 
peroxidase stain.
4) For visual illustration of our fi nding we used 
Leica DC 300F camera and the image processing and 
analysis software Image-Pro Plus Version 6.0.
The intensity of immunostaining was graded 
semi-quantitatively. Scale was as following: "0" – 
no positive structures found in visual fi eld, "0/+" – 
occasional positive structures seen in visual fi eld, 
"+" – few immunoreactive structures seen in visual 
fi eld, "++" – moderate number of immunoreactive 
structures seen in visual fi eld, "+++" – numerous 
immunoreactive structures seen in visual fi eld, and 
"++++" – abundance of immunoreactive structures 
seen in visual fi eld (20).
Results of TUNEL method were obtained by 
counting apoptosis positive cells in fi ve unintention-
ally chosen fi elds of vision.
Analysis of the data
Statistical analyses were performed with SPSS 
software, version 20.0 (IBM Company, Chicago, 
USA). Results were expressed as mean±SD. The 
Mann-Whitney test for comparison of study groups 
was conducted. P values <0.05 were considered sta-
tistically signifi cant. 
RESULTS
Number of MMP-2 positive oral epithelial 
cells, especially in the basal cell layer, connective 
tissue cells and salivary gland cells varied from few 
to numerous in all specimens of the control group 
and CBCLP group (Figs. 1, 2 and 3). There was no 
signifi cant difference in mean between the CBCLP 
group and the control group (z=1.65; p=0.09, z=0.32; 
p=0.77, Figs. 4 and 5).
Appearance of TIMP-2 positive oral epithelial 
cells, macrophages and fi broblasts in current study 
varied from few positive structures to numerous of 
positive structures in visual fi eld in patient with CLP 
Fig. 3. Moderate positive for MMP-2 salivary gland cells in 
cleft lip region of 4 months old child. MMP-2 IMH, ×200
Fig. 5. Comparison of MMP-2 expression in CBCLP af-
fected connective tissue and control group connective tissue 
cells. No statistically signifi cant differences were identifi ed
Fig. 2. Marked distribution of MMP-2 in subepithelial 
tissue from cleft lip region of 4 months old child. MMP-2 
IMH, ×250
Fig. 4. The graphs represent MMP-2 expression in CBCLP 
affected epithelium and control group epithelium. No sta-
tistically signifi cant differences were identifi ed
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(Fig. 6). TIMP-2 positive connective tissue cells were 
signifi cantly increased in the CBCLP group when 
compared with the control group (z=2.16; p=0.03, 
Fig. 7). Number of TIMP-2 positive oral epithelial 
cells, especially in the middle layer of oral mucosa, 
varied from few to moderate in all specimens of the 
CBCLP and the control group, showing no signifi cant 
difference in mean value between the study groups 
(z=1.33; p=0.21, Fig. 8).
Marked apoptosis affected oral epithelial cells, 
connective tissue cells, sebaceous gland cells and 
infl ammatory cells focally (Figs. 9 and 10). TUNEL-
positive cells were observed in both groups; however, 
when the cells were counted, TUNEL-positive oral 
Fig. 6. Moderate number of TIMP-2-containing oral epi-
thelial cells in the soft tissue from lip region of 11 months 
old child. TIMP-2 IMH, ×200
Fig. 8. The graphs demonstrate TIMP-2 expression in CB-
CLP and control groups epithelial tissue. No statistically 
signifi cant differences were identifi ed.
Fig. 10. Marked apoptosis in sebaceous gland cells of pa-
tient. TUNEL, ×400
Fig. 7. Comparison of TIMP-2 expression in CBCLP af-
fected connective tissue and control group connective tissue 
cells. Signifi cant differences between groups were observed
Fig. 9. Marked apoptosis of oral epithelial cells and con-
nective tissue cells in patient. TUNEL, ×200
Fig. 11. Comparison of apoptotic epithelial cells using 
TUNEL method in patient and control groups. Signifi cant 
differences between groups were observed.
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22). MMPs and their inhibitors are widely expressed 
during embryonic development. These proteinases 
responsible for extracellular matrix turnover may be 
implicated in cleft palate. The enzyme MMP-2, also 
known as gelatinase A, signifi cantly contribute to 
mouse palate development and the aberrant expres-
sion or function of the enzyme could be involved in 
causing facial abnormalities, such as CLP (23, 24). 
MMP-2 is expressed in almost all human tissues, and 
chiefl y present in connective tissue cells, endothelial 
and epithelial cells. The MMP-2 activity is regulated by 
TIMP-2, TIMP-3 and TIMP-4. Appearance of MMP-2 
positive cells in current study varied from moderate 
positive structures to numerous of positive structures in 
visual fi eld in previously mentioned patient with CLP. 
Expression of MMP-2 was observed in the tissues of 
all patients. Considering the foregoing, we suggest that 
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In the present study, the number of TIMP-2 posi-
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abundance of cells in programmed cell death condition. 
Feasibly it is dependent apoptosis, which is related to 
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is a genetically regulated process of cell elimination 
that plays role in biological processes, such as embry-
onic development to aging, normal and pathological 
tissue homeostasis, as well as normal tissue turnover. 
Thus, development of the lip and palate is a complex 
process in which apoptosis plays a vital role in crani-
ofacial development. Failure of programmed cell death 
to occur in the epithelial edge could contribute to the 
development of CLP. It is possible that variation in 
anti-apoptotic genes involved in apoptosis may be re-
sponsible for some of the predisposition to CLP (28-29). 
CONCLUSIONS
TIMP-2 positive connective tissue cells increas-
ingly found in oral mucosa lamina propria proves the 
decrease of local apoptosis in CLP patients. Promi-
nent expression of MMP-2 in cleft affected soft tissue 
indicates a possible increase of tissue remodelling.
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